
The Federal Trade Commission says just three big companies control 80 percent of prescription drug pricing. Minnesota-based Optum RX, CVS Caremark and Express Scripts are now accused of marking up prices. Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and driving independent pharmacists out of business. What we know: The FTC released a study on Tuesday that outlined what it called a "growing profit center" for PBMs like Minnesota-based Optum...